The
global hepatitis
drugs market was valued at $23,222.1 million in 2014,
and it is expected to grow with a CAGR of 29.7% during 2015 - 2020. The global hepatitis
drugs market is growing due to increasing
incidences of hepatitis and increasing support from government organizations.
In addition, the growing geriatric population, and increasing R&D
investments on hepatitis research and drug discovery are also driving the
growth of the global hepatitis drugs market.
Among
the various types, the hepatitis C segment is expected to be the largest segment,
and expected to witness the fastest growth during the forecast period, with a
CAGR of 30.7%.
Explore Report with Detailed TOC on
“Global Hepatitis Drugs Market” at: https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market
The
information and data in the publication “Global
Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to
2020” represent the research and analysis of data from various primary and
secondary sources. The bottom-top approach has been used to calculate the global
market size by type and drugs. The market numbers for countries are obtained
through top-down approach. P&S Market Research analysts and consultants
interacted with the authorities from leading companies of the concerned domain,
to substantiate every value of data presented in this report. The company bases
its primary research on discussions with prominent professionals and analysts
in the industry, which is followed by informed and detailed, online and offline
research.
Ask for Sample Pages: https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market/report-sample
The increasing incidences
of various types of hepatitis, such as hepatitis B, and hepatitis C are playing
a pivotal role in the growth of the global hepatitis drugs market. According to
the Hepatitis B Foundation, a non-profit organization solely dedicated to the
global problem of hepatitis B, approximately 400 million people globally were
chronically infected with hepatitis B, as reported at the end of September 2015. According
to the World Health Organization (WHO), an estimated 130 - 150 million people
globally were reported to suffer from hepatitis C, as of July 2015. The
increasing incidences of hepatitis have increased the demand of therapeutic
drugs for the management of diseases.
However,
the high
capital expenditure and stringent regulatory requirements are inhibiting the
growth of the market. The growing number
of collaboration and partnerships is one of the latest trends observed in the market.
Geographically, North America dominated the
global market of hepatitis drugs in 2014; whereas the Asian market is expected
to witness the fastest growth, with a CAGR of 32.4% during the forecast period.
The
key companies operating in the global hepatitis drugs market include Gilead
Sciences Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck &
Co. Inc., GlaxoSmithKline PLC, AbbVie Inc., Novartis AG, Bristol-Myers Squibb
Company, Dynavax Technologies Corporation, and Mitsubishi Tanabe Pharma
Corporation.
GLOBAL HEPATITIS
DRUGS MARKET SEGMENTATION
Ø Hepatitis A
Ø Hepatitis B
Ø Hepatitis C
Ø Others
By Drug
Ø Hepatitis B Drugs
o Baraclude
o Viread
o Pegasys
o Tyzeka
o Hepsera
o Others
Ø Hepatitis C Drugs
o Sovaldi
o OLYSIO
o Harvoni
o Pegasys
o PegIntron
o Victrelis
o Others
Ø
North America
o
The U.S.
o
Canada
o
Rest of North America
Ø
Europe
o
Germany
o
France
o
The U.K.
o
Rest of Europe
Ø
Asia
o
Japan
o
China
o
India
o
Rest of Asia
Ø
Rest of the World (RoW)
About P&S Market Research
P&S Market Research is a market
research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports, industry
forecasting reports, business intelligence, and research based consulting
services across different industry/business verticals.
As one of the top growing market research
agency, we’re keen upon providing market landscape and accurate forecasting.
Our analysts and consultants are proficient with business intelligence and
market analysis, through their interaction with leading companies of the
concerned domain. We help our clients with B2B market research and assist them
in identifying various windows of opportunity, and framing informed and
customized business expansion strategies in different regions.
Contact:
Abhishek
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Web:
https://www.psmarketresearch.com
No comments:
Post a Comment